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Background/aim: Brucella endocarditis, which is a rare condition, is the most common cause of death in human brucellosis, leading to
severe cardiac complications. By collecting and analyzing clinical cases, we analyzed the clinical characteristics and outcome of Brucella
endocarditis in endemic areas in China.
Materials and methods: Presented here are 5 cases of Brucella endocarditis, all managed uniformly. We present the clinical, serological,
and echocardiographic features; the therapeutic approach; and the follow-up of five patients with Brucella endocarditis.
Results: There was a predominance of aortic involvement (4 cases) and a high incidence of left ventricular failure (5 cases). Polymerase
chain reaction (PCR) testing was positive in all five patients. Diagnostic suspicion was essential in order to test blood cultures correctly,
which in this series were positive in 3 patients. In the follow-up postoperative period of a minimum of 24 months, the patients suffered
rare relapse in terms of either the infection or the dysfunction in terms of prosthesis after 3-month antibiotic therapy, with only one
exception that died within that period.
Conclusion: We should pay attention to Brucella infections and strengthen public awareness and education. It is necessary to screen for
and recognize Brucella endocarditis cases early and to provide adequate antibiotic treatment.
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1. Introduction
Infective endocarditis has an estimated annual incidence of
3 to 9 cases per 100,000 persons in industrialized countries,
and it is a disease characterized by high morbidity and
mortality (1–5). There are many pathogens that can cause
endocarditis. Among these, gram-positive bacteria were
shown to represent the predominant etiological agent (6).
However, Brucella species, which are gram-negative bacilli,
can also cause this disease and clinical manifestations
are diverse. Brucella species are intracellular pathogens
that are transmitted primarily through consumption of
unpasteurized products. Complications due to Brucella
infection develop in 25% to 35% of patients, most
commonly involving the osteoarticular system, followed
by the genitourinary, central nervous, and cardiovascular
systems (6).
Here we describe the importance of considering
Brucella as an etiological agent for endocarditis in Jilin
Province, which is located in the northeastern part of
China, which is a brucellosis-endemic region. We describe
the clinical, serological, and echocardiographic features
and our therapeutic approach as well as the follow-up of
five patients with Brucella endocarditis.
* Correspondence: wangfeng3077@163.com

2. Materials and methods
We retrospectively identified 286 patients with suspected
endocarditis (2003–2012) in the first hospital of Jilin
University, Changchun city, Jilin Province. All patients
suspected of suffering from endocarditis were examined
by transthoracic echocardiography. Serological testing for
brucellosis and blood cultures on routine liquid media
were performed with patients who reported ingestion of
unpasteurized milk and milk products from goats or cattle,
or contact with secretions from these animals and their
tissues. The diagnosis of brucellosis was made according
to one of the following criteria: 1) isolation of Brucella spp.
from blood or tissue samples; 2) brucellosis-compatible
clinical manifestations and demonstration of specific
antibodies at substantial titers (Wright’s seroagglutination
titer > 1:160 or a Coombs’ antibrucella test titer > 1:320).
Serological tests were performed in accordance with the
World Health Organization recommendations (7).
Blood samples were cultivated using a nonradiometric
system, Bactec 730 or 9240, which was half automatic.
Based on the usual microbiologic skills, the blood cultures
were thus processed (8). The maintenance for incubation
lasted for 30 days, while the subcultures were conducted
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with chocolate agar as well as the Brucella one after
10, 20, and 30 days. As for those subcultures, they were
cultured at the temperature of 37 °C with a 5%~10% CO2
environment, lasting for 3 days. Moreover, through such
methods as morphology, oxidase, urease tests, and Gram
staining as well as catalase and positive agglutination along
with specific antiserum, suspect colonies have thus been
recognized and identified. Furthermore, in the National
Reference Laboratory situated in Valladolid, the isolated
strains were finally identified before the biotyping.
The clinical diagnosis of endocarditis was made in
accordance with the Duke criteria (9). Patients with both
endocarditis and brucellosis were considered to have
Brucella endocarditis. In the patients who experienced
cardiac surgery, the diagnosis was confirmed in both a
microbiological and/or histological way.
In the first 6 months, the patients would accept the
monitoring every 2 months in the case of favorable
disease course and no matter when it was necessary on the
condition of the presence of complications. After that, the
patients were monitored every 4 months, with a minimum
observation period of 24 months.
3. Results
The reported rates of endocarditis after Brucella infection
vary (10). In our study, 286 patients suspected of
endocarditis were evaluated by using the above methods.
Endocarditis was confirmed in 189 patients and Brucella

was identified as the etiological agent in five patients (3%,
5/189). There were four male patients (80%, 4/5) and one
female patient (20%, 1/5), with a median age of 41.8 years,
ranging from 18 to 65 years (Table 1). All patients had
a clear contact history such as exposure to their own or
their neighbor’s domestic sheep, or raw milk ingestion.
Underlying cardiopathy was present in two patients (40%,
2/5): rheumatic cardiopathy in one and a bicuspid aortic
valve in the other (Table 2). The endocarditis involved the
aortic valve in four cases (80%, 4/5) and the mitral valve
in one (20%, 1/5) (Table 2). All patients (100%, 5/5) had
left ventricular failure at the time of diagnosis or shortly
thereafter (Table 2).
The polymerase chain reaction (PCR) test was positive
in all patients (100%, 5/5) (Table 3). The blood cultures
were positive in three patients (60%, 3/5), with Brucella
melitensis being isolated in all (Table 3). The two patients
with negative blood cultures had received previous
antibiotic therapy (Table 4). There was evidence of antiBrucella antibodies in all cases, with high titers in at least
one of the serologic tests used (Table 3).
Two of the 5 patients (40%, 2/5) were treated with
doxycycline (200 mg/day) plus rifampicin (900 mg/day)
for 3 months, with the incorporation of ciprofloxacin (1
g/day i.v.) during the first 6 weeks (Table 4). The other
patient was not given ciprofloxacin because of an upset
stomach, receiving instead doxycycline and rifampicin for
3 months (Table 4).

Table 1. The year of disease, sex, and age of 5 patients with Brucella endocarditis.
No.

The year of disease

Sex

Age (years)

1

2003

Male

18

2

2005

Male

58

3

2009

Male

26

4

2011

Male

65

5

2013

Female

42

Table 2. Main clinical features of 5 patients with Brucella endocarditis.
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No.

Underlying cardiopathy

Valve

Left ventricular failure

1

None

Aortic

Yes

2

Rheumatic cardiopathy

Aortic

Yes

3

None

Aortic

Yes

4

Bicuspid aortic valve

Aortic

Yes

5

None

Mitral

Yes
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Table 3. Main clinical diagnostic method in 5 patients with Brucella endocarditis.
No.

PCR

Serum agglutination test

Blood cultures

1

+

1/200

+

2

+

1/400

–

3

+

1/400

+

4

+

1/400

–

5

+

1/400

+

Table 4. Treatment method and clinical outcome of 5 patients with Brucella endocarditis.
No.

Antibiotic treatment

Surgery

Outcome

1

Doxycycline + rifampin

Yes

Died

2

Doxycycline + rifampin + ciprofloxacin

Yes

Favorable

3

Doxycycline + rifampin

No

Favorable

4

Doxycycline + rifampin

Yes

Favorable

5

Doxycycline + rifampin + ciprofloxacin

Yes

Favorable

One patient died during the immediate postoperative
period (20%, 1/5). Four patients underwent surgery in
addition to antibiotic therapy (80%, 4/5). The others were
monitored for at least 2 years, with no evidence of relapse
of infection or prosthetic dysfunction detected.
4. Discussion
While human Brucella infections have become an
uncommon phenomenon in western countries, they still
impose a significant burden on many Mediterranean,
Middle Eastern, Asian, and South American countries
(11). According to the Chinese Ministry of Health, until
1980 the incidence in China was highest in the provinces
of Inner Mongolia, Jilin, and Heilongjiang, all of which are
located in northeastern China. However, since 2000 the
prevalence has been highest in the western central Chinese
provinces of Shanxi, Hubei, and Henan. Tibet remains a
region with increased endemicity (12). Notably, there is
a steep increase in the annual incidence. Jilin Province is
located in northeastern China, where stock breeding is
one of the main economic resources.
Brucellosis has classically been categorized as acute,
subacute, or chronic. Human brucellosis is traditionally
described as a disease with various manifestations.
Fever accompanied by rigors, malodorous perspiration,
lymphadenopathy, hepatomegaly, and splenomegaly is
often present.
Among the different manifestations of brucellosis,
endocarditis remains the principal cause of Brucella-

associated mortality. Endocarditis develops gradually
and the time between infection and onset of endocarditis
is unknown. Furthermore, it is unknown whether
these bacteria can be eliminated. Among the cardiac
complications associated with endocarditis are
paravalvular leakage, ring abscess, congenital heart disease
(ventricular septal defect), rheumatic heart disease, and
acute valve malfunction. Extracardiac manifestations such
as sepsis, septic shock, renal failure, pneumonia, blood
disseminated pulmonary abscess, liver abscess, sacroiliitis,
and encephalopathy were reported (13). Osteoarticular
disease is universally the most common complication
of brucellosis and the reproductive system is the second
most common site of focal brucellosis. Brucella-associated
hepatitis is also commonly observed. While according to
most studies the central nervous system is affected in 5%
to 7% of cases, respiratory complications of brucellosis are
considered rare (14).
The diagnosis for brucellosis is not easy despite the
high degree of suspicion. Moreover, there is lack of
sufficient sensitivity for the blood culture, while for the
serologic tests they are not completely specific despite
the sensitiveness. Hence, there can be difficulty in terms
of the interpretation in fields where the disease tends to
be endemic. Furthermore, it could be negative in the early
phase of the disease. When it comes to the diagnosis in
terms of the focal forms concerning brucellosis, it may be
extremely hard as it may not become a potential symptom
for the physician, or that, there can be low production
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of cultures acquired from both the blood and nonblood
samples despite the consideration (15,16).
It is quite common for the young male to suffer
frequent infection in brucellosis. Moreover, most of them
would once be exposed to Brucella spp. For developed
countries, brucellosis could be the only element affecting
people concerned with the following professions, including
farmers and people engaged in animal husbandry as well
as veterinarians. However, not all patients are in related
professions with high risks. In reality, the major infection
route lies in drinking milk products (17), which could
explain why there have been five patients contracting
brucellosis by this route. Furthermore, as the only species
isolated, Brucella melitensis could occur in other nations
of the field (17).
As can be noted from this series, the aortic valve was
predominantly involved, accounting for 80% (4/5) of the
total, in which half the patients had potential cardiopathy.
Nowadays, patients suffering from mitral endocarditis are
prone to suffer from rheumatic cardiopathy, especially
when Brucella spp. attack the valve (18,19).
The most popular complication is left ventricular
failure. In our series, it happened in every case. This
hemodynamic change results from long-time symptoms,
which do great harm to the valve. Generally speaking, this
hemodynamic change is identified when the disease is
diagnosed or shortly after the diagnosis.
Several diagnostic tests are available for brucellosis,
such as culture (whole blood or bone marrow culture),
serodiagnosis (agglutination tests, enzyme-linked
immunoassay, 2-mercaptoethanol test) and molecular
detection (PCR). PCR testing was positive in all five patients
(100%, 5/5). Compared with endocarditis resulting from
other kinds of bacteria, Brucella endocarditis is usually
related to a quite high ratio of negative blood cultures, as
Brucella spp. reproduce slowly and demand proper culture
medium. In addition, it is usually part of endocarditis
with negative blood cultures caused by the pathogen (20).
Nevertheless, two patients with negative blood cultures
acquired the antibiotic therapy in advance. As a result, it
is necessary to implement appropriate serologic tests to

patients suffering from endocarditis as well as those with
negative blood cultures.
A pathogen like Brucella spp. is prone to lead to
fatal consequence only if it reproduces in the valvular
endocardium. It is said that the unique method to get
rid of infection related to a pathogen is combining
medical with surgical treatment. Traditionally speaking,
Brucella endocarditis is treated in the same way (21,22).
Nevertheless, serious harm is likely to be caused not so
much by the assumed poisonousness of the bacteria as by
a late diagnosis.
Brucella endocarditis is very sensitive in the diagnosis
of valvular ring abscesses, which calls for surgery at once.
The constant finding during surgery for injuries not
identified by transthoracic echocardiography will result in
the traditional transesophageal echocardiography in cases
of Brucella endocarditis.
At present, there is no definite method to deal with
Brucella endocarditis. In the case of the antibiotic field,
the best method to treat various kinds of brucellosis is
to combine doxycycline with rifampicin (23). However,
when it comes to endocarditis, ciprofloxacin is also
included due to its great tissue distribution and great
capacity to penetrate in valvular vegetations. In view of the
embolic complications as well as late period of destruction
concerning tissue in certain patients, our series produced
good outcomes. It turns out that the triple antimicrobial
therapy adopted is quite useful and is accepted well,
and that the 3-month treatment is long enough, as no
recurrence or periprosthetic infections happen.
In conclusion, the prospective series carried out helps
to identify the traits of Brucella endocarditis in terms of
diagnosis, clinics, and therapy. In the series, all the patients
are treated in the same way. It turns out that much of the
morbidity and mortality caused by Brucella endocarditis
could be treated by medical as well as surgical method.
Even though the valve can be replaced with regard to
serious valvular failure, there is an effective medical
method. In order to treat the disease effectively, it is
necessary to identify and diagnose the disease as early as
possible, especially in endemic areas.
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